Astrana Historical Balance Sheet
ASTH Stock | 33.48 0.01 0.03% |
Trend analysis of Astrana Health balance sheet accounts such as Other Current Liab of 193.3 M, Total Current Liabilities of 229.6 M or Total Stockholder Equity of 644.9 M provides information on Astrana Health's total assets, liabilities, and equity, which is the actual value of Astrana Health to its prevalent stockholders. By breaking down trends over time using Astrana Health balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Astrana Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Astrana Health is a good buy for the upcoming year.
Astrana Health Inventory |
|
Astrana |
About Astrana Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Astrana Health at a specified time, usually calculated after every quarter, six months, or one year. Astrana Health Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Astrana Health and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Astrana currently owns. An asset can also be divided into two categories, current and non-current.
Astrana Health Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Astrana Health assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Astrana Health books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Astrana Health balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Astrana Health are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Accounts Payable
An accounting item on the balance sheet that represents Astrana Health obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Astrana Health are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most accounts from Astrana Health's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Astrana Health current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.As of now, Astrana Health's Total Stockholder Equity is increasing as compared to previous years. The Astrana Health's current Net Debt is estimated to increase to about 28.6 M, while Common Stock Total Equity is projected to decrease to under 30 K.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 88.5M | 128.5M | 184.1M | 193.3M | Total Assets | 867.4M | 966.2M | 933.4M | 980.0M |
Astrana Health balance sheet Correlations
Click cells to compare fundamentals
Astrana Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Astrana Health balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 728.7M | 817.5M | 867.4M | 966.2M | 933.4M | 980.0M | |
Other Current Liab | 77.0M | 74.1M | 88.5M | 128.5M | 184.1M | 193.3M | |
Total Current Liabilities | 105.4M | 115.0M | 114.7M | 148.6M | 218.7M | 229.6M | |
Total Stockholder Equity | 191.5M | 330.8M | 448.2M | 542.6M | 614.2M | 644.9M | |
Net Debt | 153.3M | 67.1M | (32.1M) | (58.7M) | 27.2M | 28.6M | |
Retained Earnings | 31.9M | 69.8M | 137.2M | 182.4M | 243.1M | 255.3M | |
Accounts Payable | 6.9M | 9.6M | 5.5M | 10.5M | 9.1M | 9.5M | |
Cash | 103.3M | 193.5M | 233.1M | 288.0M | 293.8M | 308.5M | |
Cash And Short Term Investments | 219.8M | 261.2M | 286.5M | 293.6M | 296.3M | 311.1M | |
Common Stock Total Equity | 35.9K | 42K | 45K | 47K | 54.1K | 30.0K | |
Common Stock Shares Outstanding | 36.4M | 37.4M | 45.4M | 45.6M | 47.1M | 49.4M | |
Liabilities And Stockholders Equity | 728.7M | 817.5M | 867.4M | 966.2M | 933.4M | 980.0M | |
Non Current Liabilities Total | 262.2M | 257.3M | 242M | 259.1M | 303.9M | 319.1M | |
Other Stockholder Equity | 159.6M | 261.0M | 310.9M | 360.1M | 371.0M | 389.6M | |
Total Liab | 367.7M | 372.3M | 356.7M | 407.7M | 522.6M | 548.7M | |
Total Current Assets | 329.1M | 338.6M | 404.5M | 428.1M | 461.5M | 484.6M | |
Common Stock | 35.9K | 42K | 45K | 47K | 54.1K | 33.4K | |
Short Long Term Debt Total | 256.6M | 260.6M | 201.0M | 229.4M | 321.0M | 337.1M | |
Short Term Debt | 12.6M | 14.2M | 3.9M | 4.8M | 24.8M | 26.0M | |
Property Plant And Equipment Net | 26.4M | 48.5M | 68.6M | 129.0M | 44.6M | 23.8M | |
Non Current Assets Total | 399.6M | 478.9M | 462.9M | 538.1M | 471.9M | 495.4M | |
Non Currrent Assets Other | 1.7M | 19.4M | 5.9M | 4.6M | 44.6M | 46.9M | |
Net Receivables | 99.0M | 60.6M | 99.3M | 119.7M | 147.8M | 155.1M | |
Other Current Assets | 10.3M | 16.8M | 18.6M | 14.8M | 17.5M | 18.3M | |
Property Plant And Equipment Gross | 26.4M | 48.5M | 68.6M | 129.0M | 67.4M | 70.8M | |
Net Tangible Assets | 18.8M | 119.0M | 118.7M | 214.0M | 246.1M | 258.4M | |
Current Deferred Revenue | 8.9M | 13.0M | 16.8M | 531K | 744K | 706.8K | |
Noncontrolling Interest In Consolidated Entity | 786.2K | 87K | 5.9M | 2.2M | 2.5M | 1.8M | |
Other Assets | 2.4M | 55.3M | 6.5M | 6.1M | 22.1M | 12.9M | |
Long Term Debt | 232.2M | 230.2M | 182.9M | 203.4M | 258.9M | 271.9M | |
Good Will | 238.5M | 239.1M | 246.4M | 269.1M | 278.8M | 139.8M | |
Retained Earnings Total Equity | 31.9M | 69.8M | 143.6M | 192.7M | 221.6M | 232.7M | |
Short Term Investments | 116.5M | 67.7M | 53.4M | 5.6M | 2.5M | 2.4M | |
Long Term Debt Total | 232.2M | 230.2M | 182.9M | 203.4M | 233.9M | 245.6M | |
Capital Surpluse | 159.6M | 261.0M | 310.9M | 360.1M | 414.1M | 434.8M | |
Deferred Long Term Liab | 18.3M | 11.0M | 9.1M | 3.0M | 3.5M | 6.8M | |
Intangible Assets | 103.0M | 87.0M | 82.8M | 76.9M | 71.6M | 56.4M |
Currently Active Assets on Macroaxis
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 1.3 | Revenue Per Share 36.415 | Quarterly Revenue Growth 0.375 | Return On Assets 0.0449 |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.